GPS Wealth Strategies Group’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$420 Sell
150
-250
-63% -$894 ﹤0.01% 566
2025
Q3
$1.92K Sell
400
-595
-60% -$3.79K ﹤0.01% 1416
2025
Q2
$9.05K Sell
995
-125
-11% -$921 ﹤0.01% 1062
2025
Q1
$10.1K Hold
1,120
﹤0.01% 997
2024
Q4
$14.6K Hold
1,120
﹤0.01% 867
2024
Q3
$17.6K Sell
1,120
-189
-14% -$2.86K ﹤0.01% 827
2024
Q2
$17.7K Hold
1,309
﹤0.01% 785
2024
Q1
$36.3K Hold
1,309
0.01% 583
2023
Q4
$25.2K Hold
1,309
﹤0.01% 643
2023
Q3
$21.2K Sell
1,309
-100
-7% -$1.77K ﹤0.01% 682
2023
Q2
$26.8K Buy
1,409
+125
+10% +$2.23K 0.01% 633
2023
Q1
$18.7K Buy
+1,284
New +$23K ﹤0.01% 706
2022
Q4
Sell
-1,284
Closed -$31K 779
2022
Q3
$31K Sell
1,284
-150
-10% -$4.62K 0.01% 524
2022
Q2
$45K Buy
1,434
+550
+62% +$19.9K 0.01% 460
2022
Q1
$39K Hold
884
0.01% 463
2021
Q4
$38K Hold
884
0.01% 462
2021
Q3
$28K Hold
884
0.01% 509
2021
Q2
$37K Hold
884
0.01% 471
2021
Q1
$33K Buy
+884
New +$27.6K 0.01% 455

Other funds holding ACH

GPS Wealth Strategies Group's ACH Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its Accendra Health (ACH) stake by 63% in Q4 2025, selling an estimated $894 and leaving 150 shares worth $420. The position accounts for ﹤0.01% of the portfolio, ranked #566.

GPS Wealth Strategies Group first reported a position in ACH in Q1 2021 and has held it in 19 quarters since. The position peaked at $45K in Q2 2022. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.

  • GPS Wealth Strategies Group held 150 shares of Accendra Health worth $420 as of Q4 2025.
  • GPS Wealth Strategies Group sold 250 Accendra Health shares in Q4 2025, an estimated $894.
  • Accendra Health made up ﹤0.01% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #566 holding.
  • GPS Wealth Strategies Group first reported a position in Accendra Health in Q1 2021 and has held it in 19 quarters since.
  • GPS Wealth Strategies Group's Accendra Health position peaked at $45K in Q2 2022.
  • 168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.